Creso Pharma’s (ASX:CPH) goal is to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
CPH Delivers Over 3 Million Anibidiol Doses to Europe's Dogs
Jan 21, 2020
Momentum has been building over the last couple of months as CresoPharma (ASX:CPH) outlined its strategy for generating substantial growth in 2020.
Canada Legalises Cannabis as CPH Moves Front and Centre With a 100% Owned Canadian Growing Facility
Oct 18, 2018
CPH Gets Green Light to Distribute its Innovative CBD Based Nutraceutical Products in the UK
Jan 18, 2018
CPH Seal Swiss Pharma Deal: Setting the Cornerstone for Global Commercialisation of cannaQIX
Dec 4, 2017
CPH to Acquire Canadian Cannabis Grower and Strengthen Position in Multi-Billion Dollar Market
Jul 27, 2017
First Cannabis Revenues in Sight for CPH
Nov 7, 2016